The chief development officer of Anixa Biosciences discussed the company’s trial of a CAR-T in ovarian cancer that is looking at the effect of regional administration and lymphodepletion on efficacy.
Pamela Garzone, PhD
Advertisement
Articles by Pamela Garzone, PhD
The chief development officer of Anixa Biosciences discussed how the company is tackling 2 major challenges presented by solid tumors in its ovarian cancer clinical trial.
Advertisement
Latest Updated Articles
Pamela Garzone, PhD, on Exploring Unknowns in CAR-T for Solid TumorsPublished: September 7th 2023 | Updated:
Pamela Garzone, PhD, on Tackling Challenges of Treating Solid Tumors With CAR-TPublished: September 5th 2023 | Updated:
